Efficacy of avelumab + axitinib vs sunitinib by IMDC risk group in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 Meeting Abstract
| Authors: | Haanen, J.; Larkin, J.; Choueiri, T.; Albiges, L.; Rini, B.; Atkins, M.; Schmidinger, M.; Penkov, K.; Thomaidou, D.; Wang, J.; Mariani, M.; di Pietro, A.; Motzer, R. |
| Abstract Title: | Efficacy of avelumab + axitinib vs sunitinib by IMDC risk group in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 |
| Meeting Title: | 2021 ANZUP Annual Scientific Meeting: A Clearer Vision During Change |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 17 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2021 Oct 17-18 |
| Meeting Location: | Virtual |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-10-01 |
| Start Page: | 51 |
| Language: | English |
| ACCESSION: | WOS:000705028800035 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.13700 |
| PUBMED: | 34632712 |
| Notes: | Meeting Abstract: #abs20 -- Source: Wos |
